Medical/Pharmaceuticals
TrialWire Awarded by Frost & Sullivan for Innovative Clinical Trial Patient Recruitment Technology Platform
TrialWire delivers superior trial patient recruitment solutions based on highly sophisticated information technology (IT) all in one secure platform SAN ANTONIO, Dec. 8, 2022 /PRNewswire/ -- Based on its recent analysis of the clinical trial patient recruitment IT solutions industry,Frost & Sulli...
2022-12-08 22:00
2969
SonarMed™ airway monitoring system Applauded by Frost & Sullivan for Providing Real-time Visualization for Accurate Troubleshooting with Its Endotracheal Tube Airway Monitor
The SonarMed™ system is the first and only FDA-cleared airway monitoring system that provides heightened patient safety, cost savings, and quality measures while lowering average LOS in the NICU. SAN ANTONIO, Dec. 8, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the neonatal care indus...
2022-12-08 21:00
1958
Antengene Appoints Amily Zhang as its Chief Medical Officer
SHANGHAI and HONG KONG, Dec. 8, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...
2022-12-08 08:30
2684
HARRISON.AI NAMED ON THE 2022 CB INSIGHTS' DIGITAL HEALTH 150 LIST
The clinician-led technology platform has been recognized for achievements in
computer-aided imaging
NEW YORK, Dec. 8, 2022 /PRNewswire/ -- CB Insights
2022-12-08 06:00
2386
Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by China NMPA
--The objective of Phase I clinical trial is to identify a safe and efficacious dose for the pivotal Phase II/III in COVID-19 patients. Phase I clinical trial is expected to be completed within the first quarter of 2023 --Phase I clinical trial will also determine if ASC11 needs to be boosted by ...
2022-12-07 18:10
2708
Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood
Leniolisib was well tolerated and significant improvement over placebo was notable in the co-primary endpoints, reflecting a favorable impact on patients' immune dysregulation and deficiency The peer-reviewed publication heightens international understanding of APDS, a rare and recently characte...
2022-12-07 14:00
2728
Apollo Proton Cancer Centre successfully performs Asia's 1st Brain Bypass Surgery on twin children with Moya Moya Disease
CHENNAI, India, Dec. 7, 2022 /PRNewswire/ -- Apollo Proton Cancer Centre (APCC) recently performedAsia's first brain bypass surgery on twin 8-year-old children fromthe Netherlands. The integration of advanced technology and expertise at APCC helped the children to undergo surgery and recover quic...
2022-12-07 13:17
2735
PGTG successfully develops SGF bone-derived factor to restore the skeletal system
BEIJING, Dec. 7, 2022 /PRNewswire/ -- The bone-derived skeletal growth factor (SGF), jointly developed by a research facility under the direction of leading biochemist, academician and researcher Zhao Yufen and theAnhui-based research center of one of the world's health industry leaders People's ...
2022-12-07 12:00
1690
SmartFuture launches SDK to enable plug-and-play Remote Patient Monitoring in existing healthcare payer and provider applications
SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- SmartFuture, a leading health-tech company and provider of integrated RPM (Remote Patient Monitoring) solutions, has launched anRPM SDK (Software Development Kit) product. SmartFuture's RPM SDK product allows healthcare providers and payers to integrate wh...
2022-12-07 10:36
2462
Suvoda Launches eCOA-Specific Language and Design Toolkit as Solution Moves to Second Phase of Early Adopter Program
Practical, innovative functionality seeks to alleviate eCOA burdens, reduce time-to-launch, and improve site, clinician, and patient experience. PHILADELPHIA, Dec. 7, 2022 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic ar...
2022-12-07 08:00
1816
Veeva Pulse Shows Digitally Enabled Field Teams are Using HCP Time More Effectively in Asia Pacific
HCP Access is selective as nearly half meet with only one company monthly
SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- Veeva Systems
2022-12-07 08:00
2346
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering
SYDNEY, Dec. 7, 2022 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd (OTC Pink® Open Market: PARNF) ("Parnell") today commenced its previously announced backstopped rights offering to raise gross proceeds of approximatelyUS$4.0 million (the "Rights Offering"). Under the terms of the Rights O...
2022-12-07 07:00
2976
New International Consensus on CGM Clinical Trial Metrics Aims to Spur Diabetes Treatment Advances
SAN FRANCISCO, Dec. 7, 2022 /PRNewswire/ -- The diaTribe Foundation, Advanced Technologies & Treatments for Diabetes (ATTD), and the Time in Range Coalition announced today a new international consensus regarding continuous glucose monitoring (CGM) metrics for clinical trials to help accelerate t...
2022-12-07 01:26
1940
Healthcare Summit Convened to Address Maternal-Fetal Outcomes in Sub-Saharan Africa
ROCKVILLE, Md., Dec. 6, 2022 /PRNewswire/ -- Inteleos, a non-profit global healthcare certification organization and Kenya Healthcare Federation, a membership-based organization that serves as the umbrella body forKenya's Private Health Sector, hosted a maternal and fetal ultrasound summit onNov....
2022-12-06 23:00
1978
Turn Biotechnologies Changes Paradigm in Skin Rejuvenation
* Data unveiled at four industry conferences suggest a single ERA treatment may be more effective than combination therapies used today * Biomarker analysis demonstrates ERA's regenerative impact on fibroblast proliferation, collagen VII production * eTurna™ lipid-based delivery platform p...
2022-12-06 22:00
2552
CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL
Corvia® Atrial Shunt has the potential to change the way heart failure is treated TEWKSBURY, Mass., Dec. 6, 2022 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a globa...
2022-12-06 20:04
1361
Clarivate Expands Real World Data and Analytics Solutions with Addition of U.S. Specialty Pharmacy Data
LONDON, Dec. 6, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the inclusion of linked specialty pharmacy claims data within real world datasolutions. The new U.S. dataset will ex...
2022-12-06 18:20
1854
GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS
SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- Recently, Selecxine, a partner of GenScript ProBio, announced MFDS clearance of its phase I/II clinical trial application for innovative antibody drug program (SLC-3010) . GenScript ProBio extended congratulations on this. SinceDecember 2019, GenSc...
2022-12-06 17:14
2626
University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health
TOKYO, Dec. 6, 2022 /PRNewswire/ -- - World's First Research into Relationship between Rich-in-Biodiversity Garden Greenery and Health/Well-being - The University of Tokyo's Graduate School of Agricultural and Life Sciences (GSALS) and Sekisui House, Ltd. launched a joint research project on b...
2022-12-06 14:00
1758
BSR KOREA Introduces "Healcerion Co., Ltd." as "2022 Global Procurement Marketer"
SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...
2022-12-06 11:00
2146
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
9065
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
7332
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
6976
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
6749
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
6707
